Gene therapy added to cancer fight for toughest breast tumors
NCT ID NCT04095689
Summary
This study tested whether adding a gene therapy to standard chemotherapy and immunotherapy could help shrink tumors in people with triple-negative breast cancer that hadn't responded to previous treatment. The approach aimed to boost the immune system's ability to attack cancer cells. The trial was small and ended early, so results are limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.